MAERTENS, Johan, BERTZ, Hartmut und CORDONNIER, Catherine, 2022. Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091). Freiburg: Universität.
Elsevier - Harvard (with titles)Maertens, J., Bertz, H., Cordonnier, C., 2022. Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091). Universität, Freiburg. https://doi.org/10.1093/cid/ciac623
American Psychological Association 7th editionMaertens, J., Bertz, H., & Cordonnier, C. (ca. 2022). Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091) [Cd]. Universität. https://doi.org/10.1093/cid/ciac623
Springer - Basic (author-date)Maertens J, Bertz H, Cordonnier C (2022) Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091). Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Maertens, Johan/ Bertz, Hartmut/ Cordonnier, Catherine, Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091), Freiburg 2022.